In chronic asthma models, naringenin treatment resulted in decreased AHR, inflammation, and remodeling, alongside reduced levels of serum IgE and Th2 cytokines, all of which indicate its role in delaying airway remodeling and asthma progression [235]. Here, IGHE is linked to asthma.